Heart Failure in Women: A 20-year Perspective and Beyond

Maternal mortality in the United States is significantly higher than other industrialized nations, and it is at its highest level since 1965. A particular area of crisis is within peripartum cardiomyopathy (PPCM), which is a major cause of pregnancy-related deaths. In this presentation, Dr. Deborah Crabbe, Cardiologist at Temple University Hospital and Professor of Medicine at Lewis Katz School of Medicine at Temple University, outlines the REBIRTH Trial, a randomized trial that reviews the use of bromocriptine therapy for the treatment of PPCM.  

REBIRTH is a trial that will randomize 200 women at 60 centers across North America to determine if bromocriptine therapy improves myocardial recovery for women with PPCM. Temple University Hospital is participating in this study, and is looking for patient referrals. To refer a patient for this study, please call 215-707-3898.

Refer a patient for the REBIRTH Trial

Created by

Temple Health


Deborah Crabbe, MD, FACC, FAHA

Deborah Crabbe, MD, FACC, FAHA

Professor, Medicine
Lewis Katz School of Medicine
Temple University

View full profile